Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans (Q44726979)

5 December 2017

Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans (English)

1 reference

5 December 2017

0 references

1 reference

1 reference

Bente Klarlund Pedersen

series ordinal

6

1 reference

5 December 2017

Flemming Dela

3

0 references

Kirsten Møller

object named as

Kirsten Møller

series ordinal

2

0 references

Rikke Krogh-Madsen

series ordinal

1

object named as

Rikke Krogh-Madsen

1 reference

5 December 2017

5

Sune Jauffred

1 reference

5 December 2017

Gitte Kronborg

4

1 reference

5 December 2017

13 January 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

5 December 2017

1 reference

5 December 2017

286

1 reference

5 December 2017

5

1 reference

5 December 2017

E766-72

1 reference

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

5 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Interaction between free fatty acids and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Regulation of glucose metabolism by norepinephrine in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Immune dysfunction in patients with diabetes mellitus (DM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Metabolic effects of interleukin-6 in human splanchnic and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Stress-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Metabolic derangements in sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Experimental models of gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Short-term effects of tumor necrosis factor on energy and substrate metabolism in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Effects of total parenteral nutrition with nucleoside and nucleotide mixture on D-galactosamine-induced liver injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Sepsis and septic shock--a review of laboratory models and a proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2003

10.1152/AJPENDO.00468.2003

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14722028